PRM looking bearishBig Head and shoulders pattern with bearish candlestick formation. Would expect downside moves.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0174 USD
−3.11 M USD
6.40 M USD
287.37 M
About PROTEOME SCIENCES PLC
Sector
Industry
CEO
Mariola Söhngen
Website
Headquarters
Cobham
Founded
1993
ISIN
GB0003104196
FIGI
BBG000P9B9W5
Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Cobham, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMSNF is 0.0260 USD — it has increased by 30.00% in the past 24 hours. Watch Proteome Sciences PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Proteome Sciences PLC stocks are traded under the ticker PMSNF.
PMSNF stock has risen by 30.00% compared to the previous week, the month change is a 4.00% rise, over the last year Proteome Sciences PLC has showed a −65.31% decrease.
PMSNF reached its all-time high on Dec 15, 2003 with the price of 4.3500 USD, and its all-time low was 0.0200 USD and was reached on Oct 28, 2024. View more price dynamics on PMSNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PMSNF stock is 23.08% volatile and has beta coefficient of 0.68. Track Proteome Sciences PLC stock price on the chart and check out the list of the most volatile stocks — is Proteome Sciences PLC there?
Today Proteome Sciences PLC has the market capitalization of 10.27 M, it has decreased by −1.57% over the last week.
Yes, you can track Proteome Sciences PLC financials in yearly and quarterly reports right on TradingView.
Proteome Sciences PLC is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PMSNF net income for the last half-year is −2.80 M USD, while the previous report showed −2.37 M USD of net income which accounts for −17.85% change. Track more Proteome Sciences PLC financial stats to get the full picture.
No, PMSNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Proteome Sciences PLC EBITDA is −3.21 M USD, and current EBITDA margin is −19.61%. See more stats in Proteome Sciences PLC financial statements.
Like other stocks, PMSNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Proteome Sciences PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Proteome Sciences PLC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Proteome Sciences PLC stock shows the sell signal. See more of Proteome Sciences PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.